Showing results (91-100 of 451) with videos related to
Sort By:
Pageof 46
Nature Clinical Practice. Gastroenterology & Hepatology|December 6, 2005
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseasesSéverine Vermeire, Gert Van Assche, Paul RutgeertsExpert Opinion on Medical Diagnostics|March 19, 2013
Role of biomarkers in the diagnosis of inflammatory bowel diseaseSeverine Vermeire, Gert Van Assche, Paul RutgeertsCore Evidence|January 12, 2011
Infliximab: the evidence for its place in therapy in ulcerative colitisGert Van Assche, Séverine Vermeire, Paul RutgeertsCurrent Opinion in Gastroenterology|June 9, 2006
Safety issues with biological therapies for inflammatory bowel diseaseGert Van Assche, Séverine Vermeire, Paul RutgeertsGastroenterology Clinics of North America|November 30, 2006
Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapiesGert Van Assche, Séverine Vermeire, Paul RutgeertsCurrent Opinion in Gastroenterology|May 7, 2009
Immunosuppression in inflammatory bowel disease: traditional, biological or both?Gert Van Assche, Séverine Vermeire, Paul RutgeertsBiologics : Targets & Therapy|August 27, 2009
Adalimumab in Crohn's diseaseGert Van Assche, Séverine Vermeire, Paul RutgeertsCurrent Opinion in Gastroenterology|November 25, 2010
Inflammatory bowel disease and colitis: new concepts from the bench and the clinicSéverine Vermeire, Gert Van Assche, Paul RutgeertsInflammatory Bowel Diseases|September 19, 2015
Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel DiseasesZhe Li, Séverine Vermeire, Dominique Bullens, et al.Frontiers in Immunology|January 9, 2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseBram Verstockt, Clémentine Perrier, Gert De Hertogh, et al.Pageof 46